Europe Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Enteral), By Product (Powder, Pills), By Application, By Module, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

Europe Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Enteral), By Product (Powder, Pills), By Application, By Module, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030

Europe Medical Foods Market Growth & Trends

The Europe medical foods market size is expected to reach USD 7.31 billion by 2030, registering a CAGR of 2.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. The ever-increasing burden of chronic diseases and the growing geriatric population across Europe are primary reasons for the market to flourish. In 2021, the oral route of administration accounted for the largest revenue share of 69.5%. Ease of use and high availability of medical foods in this form has contributed to the high revenue. The enteral route of administration is expected to register the fastest growth. This can be attributed to the growing geriatric population suffering from chronic diseases who are unable to consume food orally. The enteral route of administration seems to be the preferred way of administrating nutrients through medical foods to the specific needs of geriatric patients.

In the product type, the powder formulations held the largest revenue share in 2024. Owing to the vast product portfolios available in this formulation this segment has grown to a large extent. Powder formulations include nutrient mixes, protein shakes, and infant feeding formulas. The highest growth was registered by the liquid formulations due to the diversification of product portfolios of the key players in the medical foods industry. Cancer had the largest revenue share in 2024 in the applications segment. Nutritional deficiency in cancer patients is a major concern and can be managed through proper nutrient management via medical foods and is a major factor in its growth. The fastest-growing sub-segment is diabetic neuropathy, high prevalence, and has been a key driver for its fast growth.

The largest sales channel for 2024 was direct-to-consumer, owing to the emerged as a significant channel within the market, providing opportunities for manufacturers to engage directly with consumers and tailor their offerings to meet specific health needs.

Europe Medical Foods Market Report Highlights

• Based on route of administration, the oral segment accounted for the largest revenue share of 76.1% in 2024 owing to high product type availability and ease of administration
• In 2024, the powder formulation segment accounted for the largest revenue share of 35.2% owing to the majority product portfolio available in the market
• By application, the cancer application segment dominated the market with the largest share of 11.7% in 2024
• The institutional sales channel had the largest share, but the online sales channel is expected to grow at a steady rate owing to the preference of consumers and key player initiatives for sales through online channels

Please note The report will be delivered in 2-3 business days upon order notification.